HSTM HealthStream
HealthStream earnings company data as of 8:01 PM ET 10/22
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 2 Nov | EPS | 0.15 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by HSTM's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $4.5M sold by 4 insiders outside a trading plan
- $274K sold by 1 insider under 10b5-1 plans
-
Robert A Frist Jr. CEOSale$4.3M 144,068 shares at $29.50 3.6% of stakeTraded Sep 14 Filed Sep 15
-
Linda Rebrovick DirectorPlanned sale$174K 6,000 shares at $29.00 11% of stakeTraded Jul 6 Filed Jul 7
-
Linda Rebrovick DirectorPlanned sale$50K 2,000 shares at $25.00 3.6% of stakeTraded Jun 1 Filed Jun 2
-
Linda Rebrovick DirectorPlanned sale$50K 2,000 shares at $25.00 3.4% of stakeTraded May 28 Filed Jun 1
-
Kevin P O'Hara Executive Vice PresidentSale$72K 3,000 shares at $24.08 13% of stakeTraded May 20 Filed May 20
-
Jeff Cunningham Chief Technology OfficerSale$51K 2,100 shares at $24.09 6.3% of stakeTraded Dec 10, 2025 Filed Dec 10, 2025
-
Kevin P O'Hara Executive Vice PresidentSale$49K 2,000 shares at $24.26 11% of stakeTraded Dec 8, 2025 Filed Dec 8, 2025
-
Tate Deborah Taylor DirectorSale$40K 1,580 shares at $25.46 6.4% of stakeTraded Nov 26, 2025 Filed Dec 1, 2025
Also filed in the last 12 months, not counted as buying or selling: 37 option exercises, 30 share withholdings for taxes, 5 gifts, 2 stock grants, and 1 sale back to the company.
SEC filings
Recent issuer filings from EDGAR, 8 shown.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.